About Estech
Estech is a Healthcare company based in San Ramon (United States) founded in 1996, and was acquired by AtriCure in December 2013. RF ablation devices for atrial fibrillation treatment are provided. Estech has raised $39 million across 3 funding rounds from investors including AtriCure, Waveland Capital Group and Saints Capital. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include AtaCor Medical, Kestra Medical Technologies and CardioFocus; 3 of its 3 listed competitors have raised funding.
Company details
Estech was founded in 1996 in San Ramon, United States, and operated in the medical devices sector for cardiac surgery. A portfolio of minimally invasive and hybrid ablation devices was offered, including temperature-controlled RF energy delivery, Versapolar technology for bipolar and monopolar energy, suction-applied tissue contact, and internally-cooled options. The company was acquired by AtriCure in 2013.
- Headquarters San Ramon, United States
- Stage Acquired
- SectorsHealthcare
- Website estech.com
- Social LinkedIn
- Acquired by AtriCure (Dec 2013)
Funding Insights of Estech
Estech has successfully raised a total of $39M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $8.5 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $39M
- Total Rounds 3
- Last Round Series C β $8.5M
- First Round $11.2M
(Dec 2008)
- Investors Count 5
All 3 funding rounds of Estech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2010 | $8.5M | Series C | β | β | |
| Jun 2009 | $19.3M | Series C | β | β | |
| Dec 2008 | $11.2M | Series B | β | β |
6 investors in total: 6 institutional.
Investors in Estech
Estech has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include AtriCure, Waveland Capital Group and Saints Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Direct secondary investments are made in private company shares. | saintscapital.com | Denver, United States | ||
Venture capital firm focused on life science, medical device and healthcare companies | thpartners.net | San Francisco, United States | ||
Healthcare investments are made by Tullis Health Investors. | tullisfunds.com | Palm Beach Gardens, United States | ||
Stage Capital is focused on private equity investments. | stagecap.com | London, United Kingdom | ||
Firm focused on oil and gas exploration and production | 2000 | wavelandgroup.com | Irvine, United States | |
Cardiac ablation and occlusion devices for atrial fibrillation are provided. | 2000 | atricure.com | Mason, United States |
Investor details for Estech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Estech
4 dated milestones of Estech across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Estech is founded.
- Funding First funding round of $11.2M.
- Funding Latest funding round, Series C, of $8.5M.
- Exit Acquired by AtriCure.
Competitors of Estech
Estech has 3 listed competitors in our database, 3 of them funded. They include AtaCor Medical, Kestra Medical Technologies and CardioFocus.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atacor.com | 2014 | San Clemente, United States | $136.8M | 15 | An implantable pacemaker system is developed for cardiac pacing therapy. | |
| kestramedical.com | 2014 | Kirkland, United States | $196M | 118 | Medical devices are developed to support cardiovascular patients at risk. | |
| cardiofocus.com | 1990 | Marlborough, United States | $260.86M | 105 | Endoscopic catheter for atrial fibrillation ablation is developed. |
Detailed competitors of Estech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Estech
Websites that share an audience with Estech (estech.com).
Websites whose visitors overlap most with Estech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| atricure.com | 21% | 18.2K | #1,529,838 | View details |
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Estech (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Estech
Estech was founded in 1996 and raised its 1st funding round 12 years after it was founded.
Estech is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Estech is a funded company, having raised a total of $39M across 3 funding rounds to date. The company's 1st funding round was a Series B of $11.2M, raised on Dec 2008.
Estech was founded in 1996 in San Ramon, United States, and operated in the medical devices sector for cardiac surgery. A portfolio of minimally invasive and hybrid ablation devices was offered, including temperature-controlled RF energy delivery, Versapolar technology for bipolar and monopolar energy, suction-applied tissue contact, and internally-cooled options. The company was acquired by AtriCure in 2013.
Estech's top competitors include AtaCor Medical, CardioFocus and Kestra Medical Technologies.
Estech has 6 investors. Key investors include AtriCure, Waveland Capital Group, Saints Capital, Telegraph Hill Partners, and Tullis Health Investors.
Yes. Estech was acquired by AtriCure in December 2013.
